Relationships between comorbidities and vitamin D intake with COVID-19 severity
Abstract
Background: Vitamin D is a nutrient/hormone-like vitamin involved in immune regulation, which, in turn, affects morbidity and mortality rates, including in coronavirus disease 2019 (COVID-19). Vitamin D strengthens both specific and nonspecific immunity and modulates the body’s response to infection. Objective: This study aims to determine the association between comorbidities and vitamin D intake with the severity of COVID-19. Methods: The study is a cross-sectional observational study with a sample comprised of 66 people, ages 19 to 58, receiving treatment for COVID-19 at Pasar Rebo District Hospital. The primary data were collected via a questionnaire administered via the WhatsApp application or through direct interviews, encompassing variables such as age, gender, comorbidity, and vitamin D intake. The Vitamin D Dietary Intake Questionnaire was conducted using the Food Frequency Questionnaire (FFQ). Vitamin D intake is categorized into two groups: low (<600 IU/day) and adequate (≥600-4,000 IU/day). Comorbidities are other illnesses that a person has, such as asthma, high blood pressure, diabetes, or heart disease. The severity of COVID-19 is an accordance with the criteria set by the Indonesian Society of Internal Medicine. Statistical analysis used SPSS version 22 to analyze univariate data and Fisher's exact test for bivariate analysis with a significance limit of p < 0.05. Results: A total of 25.8% of the subjects had comorbidities, 62.1% experienced low vitamin D intake, and 53% experienced mild COVID-19 symptoms. The severity of COVID-19 cases does not correlate with age or gender. The severity of COVID-19 cases was significantly associated with comorbidities (p=0.001) and vitamin D intake (p=0.021). Conclusion: An association was observed between vitamin D intake, comorbidities, and the severity of COVID-19.Downloads
References
Coronavirus disease (COVID-19) pandemic [Internet]. Available from: https://www.who.int/europe/emergencies/situations/covid-19
Grudlewska-Buda K, Wiktorczyk-Kapischke N, Wałecka-Zacharska E, Kwiecińska-Piróg J, Buszko K, Leis K, et al. SARS-CoV-2—Morphology, Transmission and Diagnosis during Pandemic, Review with Element of Meta-Analysis. J Clin Med. 2021 May 3;10(9):1962. doi:10.3390/jcm10091962
Samadizadeh S, Masoudi M, Rastegar M, Salimi V, Shahbaz MB, Tahamtan A. COVID-19: Why does disease severity vary among individuals? Respir Med. 2021 Apr;180:106356. doi:10.1016/j.rmed.2021.106356
Wang X, Zhang Y, Fang F. Role of vitamin D in COVID‐19 infections and deaths. J Evid-Based Med. 2021 Feb;14(1):5–6. doi:10.1111/jebm.12421
Grant W, Lahore H, McDonnell S, Baggerly C, French C, Aliano J, et al. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients. 2020 Apr 2;12(4):988. doi:10.3390/nu12040988
Indonesian Society of Internal Medicine. Buku Pedoman Tatalaksana COVID-19 [Internet]. Available from: https://www.papdi.or.id/download/1153-buku-pedoman-tatalaksana-covid-19-edisi-4-januari-2022.
Wang M, He Y, He Q, Di F, Zou K, Wang W, et al. Comparison of clinical characteristics and disease burden between early- and late-onset type 2 diabetes patients: a population-based cohort study. BMC Public Health. 2023 Dec 4;23(1):2411. doi:10.1186/s12889-023-17280-5
Cha E, Pasquel FJ, Yan F, Jacobs DR, Dunbar SB, Umpierrez G, et al. Characteristics associated with early- vs. later-onset adult diabetes: The CARDIA study. Diabetes Res Clin Pract. 2021 Dec;182:109144. doi:10.1016/j.diabres.2021.109144
Cigolle CT, Blaum CS, Lyu C, Ha J, Kabeto M, Zhong J. Associations of Age at Diagnosis and Duration of Diabetes with Morbidity and Mortality Among Older Adults. JAMA Netw Open. 2022 Sep 30;5(9):e2232766. doi:10.1001/jamanetworkopen.2022.32766
Huo X, Gao L, Guo L, Xu W, Wang W, Zhi X, et al. Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study. Lancet Diabetes Endocrinol. 2016 Feb;4(2):115–24. doi:10.1016/S2213-8587(15)00508-2
Zgaga L, Theodoratou E, Farrington SM, Agakov F, Tenesa A, Walker M, et al. Diet, Environmental Factors, and Lifestyle Underlie the High Prevalence of Vitamin D Deficiency in Healthy Adults in Scotland, and Supplementation Reduces the Proportion That Are Severely Deficient. J Nutr. 2011 Aug;141(8):1535–42. doi:10.3945/jn.111.140012
Prihashinta AW, Putriana D. Asupan Vitamin D, Frekuensi Makan dan Keluhan Gejala Gastritis pada Mahasiswa. J Nutr Coll. 2022 Apr 28;11(2):120–5. doi:10.14710/jnc.v11i2.33126
Weyand CM, Goronzy JJ. Aging of the Immune System. Mechanisms and Therapeutic Targets. Ann Am Thorac Soc. 2016 Dec;13(Supplement_5):S422–8. doi:10.1513/AnnalsATS.201602-095AW
Szeto B, Zucker JE, LaSota ED, Rubin MR, Walker MD, Yin MT, et al. Vitamin D Status and COVID-19 Clinical Outcomes in Hospitalized Patients. Endocr Res. 2021 Apr 3;46(2):66–73. doi:10.1080/07435800.2020.1867162
Vermonte P, Wicaksono TY. Karakteristik dan Persebaran COVID-19 di Indonesia: Temuan Awal [Internet]. Available from: https://csis.or.id/publication/karakteristik-dan-persebaran-covid-19-di-indonesia-temuan-awal/
Bansilal S, Castellano JM, Fuster V. Global burden of CVD: focus on secondary prevention of cardiovascular disease. Int J Cardiol. 2015 Dec;201:S1–7. doi:10.1016/S0167-5273(15)31026-3
Hurme M, Korkki S, Lehtimäki T, Karhunen PJ, Jylhä M, Hervonen A, et al. Autoimmunity and longevity: Presence of antinuclear antibodies is not associated with the rate of inflammation or mortality in nonagenarians. Mech Ageing Dev. 2007 May;128(5–6):407–8. doi:10.1016/j.mad.2007.03.001
World Health Organization (WHO). Addressing sex and gender in epidemic‐prone infectious diseases. 2007 [Internet]. Available from: https://apps.who.int/iris/bitstream/handle/10665/43644/9789241595346_eng.pdf
Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Health. 2020 Apr 29;8:152. doi:10.3389/fpubh.2020.00152
Massion SP, Howa AC, Zhu Y, Kim A, Halasa N, Chappell J, et al. Sex differences in COVID-19 symptom severity and trajectories among ambulatory adults. Influenza Other Respir Viruses. 2023 Dec;17(12):e13235. doi:10.1111/irv.13235
Klein SL, Dhakal S, Ursin RL, Deshpande S, Sandberg K, Mauvais-Jarvis F. Biological sex impacts COVID-19 outcomes. Coyne CB, editor. PLOS Pathog. 2020 Jun 22;16(6):e1008570. doi:10.1371/journal.ppat.1008570
Senewe FP, Pracoyo NE, Marina R, Letelay AM, Sulistiyowati N. Pengaruh Penyakit Penyerta/Komorbid dan Karakteristik Individu dengan Kejadian COVID-19 di Kota Bogor Tahun 2020. J Ekol Kesehat. 2021 Oct 18;20(2):69–79. doi:10.1371/journal.ppat.1008570
Karya KWS, Suwidnya IM, Wijaya BS. Hubungan penyakit komorbiditas terhadap derajat klinis COVID-19. Intisari Sains Medis. 2021 Aug 31;12(2):708–17. doi:10.15562/ism.v12i2.1143
Shah K, Varna VP, Sharma U, Mavalankar D. Does vitamin D supplementation reduce COVID-19 severity?: a systematic review. QJM. 2022 Oct 25;115(10):665-672. doi: 10.1093/qjmed/hcac040
Zhu L, Zhang Y, Li X, Zou X, Bing P, Qi M, He B. Vitamin D supplementation for managing COVID-19 in patients with vitamin D deficiency: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2025 Mar 26;15(3):e091903. doi: 10.1136/bmjopen-2024-091903
Sobczak M & Pawliczak R. Effect of Vitamin D3 Supplementation on Severe COVID-19: A Meta-Analysis of Randomized Clinical Trials. Nutrients 2024;16(10):1402. https://doi.org/10.3390/nu16101402
Utami DM, Ash-Shiddiq MAR, Rahmadhani DR, Mubarok MI, Tasman MZ, Sibarani JN, Fauziyah HTA, Utomo B, Fauziyah S. Meta-Analysis optimal dose of vitamin for Covid-19 treatment. Fol Med Indones, Vol.58 No. 4 December 2022: 383-392. doi: 10.20473/fmi.v58i4.36474
Balqis FE. Peran Vitamin D pada Infeksi Covid-19. J Penelit Perawat Prof. 3(4):669–82.
Tian Y, Rong L. Letter: Covid‐19, and vitamin D. Authors’ reply. Aliment Pharmacol Ther. 2020 May;51(10):995–6. doi:10.1111/apt.15764
Chiodini I, Gatti D, Soranna D, Merlotti D, Mingiano C, Fassio A, et al. Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes. Front Public Health. 2021 Dec 22;9:736665. doi:10.3389/fpubh.2021.736665
Submitted
Copyright (c) 2026 Verawati Sudarma, Muhammad Rifky
This work is licensed under a Creative Commons Attribution 4.0 International License.
World Nutrition Journal provides immediate open access to its content under the Creative Commons Attribution License (CC BY 4.0). This permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
